Search results
If you are looking for research summaries please go to the research summary page.
- Chief Executive, Teresa Allen, announces her retirement
- Extension of COVID-19 COPI Notice
- Pharmacy Assurance accepting new study types
- New podcast series looking at innovative trail design launches
- Support for our new transparency strategy
- Pharmacy Assurance accepting new study types from end of September
- Podcast series on complex innovative design trials
- Changes to ARSAC research application process
- Health and social care research projects for educational purposes
- COVID-19 study planning
- Radiation Assurance is expanding
- Learning lessons from ethics review of COVID-19 research
- Embracing data-driven healthcare technology
- What's next for health research?
- Update on health and social care research projects for educational purposes
- New Chief Digital Transformation Officer to help transform digital research systems
- Removal of commercial organisation information document
- COVID-19 human infection challenge vaccine studiesThe first COVID-19 human infection challenge vaccine study in the world is planned in the UK. Human infection challenge vaccine studies involve the deliberate infection of healthy volunteers. These studies can be particularly valuable for testing vaccines and can speed up the development of new vaccines.
- Technical Assurances update: MPE/CRE review procedure and generic risk statement
- Fast-track ethics review pilot opens in JanuaryA new fast-track research ethics review pilot is opening in January. The pilot will test a rapid research ethics review for global clinical and phase I trials for any disease area.